View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Mckesson Corp: 1 director

A director at Mckesson Corp sold 8,962 shares at 634.240USD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of McKesson Corporation and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 25 February 2025 in which we reassessed the appropriateness of the ratings in the cont...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: May 2, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Wedbush Research
  • Wedbush Research
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Major Base Supports Holding Following last week's pullback, a consistent theme we are seeing is that many broad market indexes and Sector ETFs are holding above (and bouncing at) major base supports. As long as these base supports continue to hold, it tells us this is likely just a normal pullback within the overall bullish trend. Important supports that we need to see hold in order to remain bullish include 4600 on the S&P 500 and 14,400 on the Nasdaq Composite. Pullbacks to Base Supports. Br...

McKesson Corporation: Update to credit analysis

McKesson's credit profile reflects its leading market position in drug distribution and conservative financial policies offset by low profitability margins and high customer concentration.

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch